Monitoring Safety and Recurrence of Paroxysmal Atrial Fibrillation after 1st cryo-balloon ablation with and without antiarrhythmic drug therapy during the 90-day blanking period ? examined with adverse event monitoring and Cardiovascular Implantable Electronic Devices (CIEDs) Save

Date Added
November 4th, 2016
PRO Number
Pro00055684
Researcher
Sultan Siddique

List of Studies

Keywords
Heart
Summary

There is no evidence regarding the rationale behind the routine short-term use of antiarrhythmic drug (AAD) therapy after cryo-balloon ablation for symptomatic paroxysmal atrial fibrillation (PAF). We seek to better understand whether the routine use of AAD post-cryo-balloon ablation makes any difference in short- or long-term success rate in maintenance of normal sinus rhythm (NSR) for symptomatic PAF patients, monitored with an implantable loop recorder. Additionally, we propose to monitor safety related events during the entire study, while particularly examining events that occur during the 90-day blanking period.

Institution
Palmetto
Recruitment Contact
Michele Neese
803-434-7614
michele.neese@palmettohealth.org

Change_preferences

-- OR --

Create_login